These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19706645)

  • 1. OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.
    Weng JR; Tsai CH; Omar HA; Sargeant AM; Wang D; Kulp SK; Shapiro CL; Chen CS
    Carcinogenesis; 2009 Oct; 30(10):1702-9. PubMed ID: 19706645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of the Akt-nuclear factor-kappa B signaling network by [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol (OSU-A9), a novel indole-3-carbinol derivative, in a mouse model of hepatocellular carcinoma.
    Omar HA; Sargeant AM; Weng JR; Wang D; Kulp SK; Patel T; Chen CS
    Mol Pharmacol; 2009 Nov; 76(5):957-68. PubMed ID: 19706731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OSU-A9 inhibits angiogenesis in human umbilical vein endothelial cells via disrupting Akt-NF-κB and MAPK signaling pathways.
    Omar HA; Arafa el-SA; Salama SA; Arab HH; Wu CH; Weng JR
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):616-24. PubMed ID: 23921148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA; Arafa el-SA; Maghrabi IA; Weng JR
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cells.
    Weng JR; Tsai CH; Kulp SK; Wang D; Lin CH; Yang HC; Ma Y; Sargeant A; Chiu CF; Tsai MH; Chen CS
    Cancer Res; 2007 Aug; 67(16):7815-24. PubMed ID: 17699787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis.
    Bai LY; Weng JR; Chiu CF; Wu CY; Yeh SP; Sargeant AM; Lin PH; Liao YM
    Biochem Pharmacol; 2013 Nov; 86(10):1430-40. PubMed ID: 24041743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel indole-3-carbinol derivative inhibits the growth of human oral squamous cell carcinoma in vitro.
    Weng JR; Bai LY; Omar HA; Sargeant AM; Yeh CT; Chen YY; Tsai MH; Chiu CF
    Oral Oncol; 2010 Oct; 46(10):748-54. PubMed ID: 20843730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OSU-A9 inhibits pancreatic cancer cell lines by modulating p38-JAK-STAT3 signaling.
    Tsai WC; Bai LY; Chen YJ; Chu PC; Hsu YW; Sargeant AM; Weng JR
    Oncotarget; 2017 Apr; 8(17):29233-29246. PubMed ID: 28418923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways.
    Siraj MA; Jacobs AT; Tan GT
    Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
    Weng SC; Kashida Y; Kulp SK; Wang D; Brueggemeier RW; Shapiro CL; Chen CS
    Mol Cancer Ther; 2008 Apr; 7(4):800-8. PubMed ID: 18413793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
    Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indole-3-carbinol inhibits protein kinase B/Akt and induces apoptosis in the human breast tumor cell line MDA MB468 but not in the nontumorigenic HBL100 line.
    Howells LM; Gallacher-Horley B; Houghton CE; Manson MM; Hudson EA
    Mol Cancer Ther; 2002 Nov; 1(13):1161-72. PubMed ID: 12479697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells.
    Rahman KM; Li Y; Sarkar FH
    Nutr Cancer; 2004; 48(1):84-94. PubMed ID: 15203382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells.
    Caruso JA; Campana R; Wei C; Su CH; Hanks AM; Bornmann WG; Keyomarsi K
    Cell Cycle; 2014; 13(16):2587-99. PubMed ID: 25486199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-3-carbinol-induced modulation of NF-kappaB signalling is breast cancer cell-specific and does not correlate with cell death.
    Moiseeva EP; Heukers R
    Breast Cancer Res Treat; 2008 Jun; 109(3):451-62. PubMed ID: 17653853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indole-3-carbinol as a chemopreventive and anti-cancer agent.
    Weng JR; Tsai CH; Kulp SK; Chen CS
    Cancer Lett; 2008 Apr; 262(2):153-63. PubMed ID: 18314259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic intervention of experimental breast cancer bone metastasis by indole-3-carbinol in SCID-human mouse model.
    Rahman KM; Sarkar FH; Banerjee S; Wang Z; Liao DJ; Hong X; Sarkar NH
    Mol Cancer Ther; 2006 Nov; 5(11):2747-56. PubMed ID: 17121921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator.
    Lee KH; Hsu EC; Guh JH; Yang HC; Wang D; Kulp SK; Shapiro CL; Chen CS
    J Biol Chem; 2011 Nov; 286(45):39247-58. PubMed ID: 21917926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.
    Nguyen HH; Lavrenov SN; Sundar SN; Nguyen DH; Tseng M; Marconett CN; Kung J; Staub RE; Preobrazhenskaya MN; Bjeldanes LF; Firestone GL
    Chem Biol Interact; 2010 Aug; 186(3):255-66. PubMed ID: 20570586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.